외과 수술용 접착제 시장 : 제품별, 용도별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

The global surgical glue market was valued at $2,340.71 million in 2021, and is projected to reach $4,614.85 million by 2031, registering a CAGR of 7.0% from 2022 to 2031.

Surgical glue is made of two components contained in separate vials; a freeze dried concentrate of clotting proteins, mainly fibrinogen, Factor XIII and fibronectin (the sealant) and freeze dried thrombin (the catalyst). The first component is reconstituted with an aprotinin solution that inhibits tissue fibrinolysis. The second component (thrombin) is dissolved with calcium chloride that is available in 500 I.U. concentration. Indications for the use of human fibrin sealant are numerous and present in all surgical branches. It is also effective in preventing local hemorrhagic complications after inguinal hernia repair in patients with concurrent coagulation disorders.

The global surgical glue market is anticipated to show significant market growth during the forecast period, owing to increase in geriatric population, increase in number of surgical procedures performed, and increase in incidence of wounds and injuries. Furthermore, increase in number of road accidents, increase in awareness regarding surgical glue and increase in prevalence of chronic diseases are considerably contributing toward the market growth. However, high cost of surgical glues and availability of alternate products and unpopularity of minimally invasive surgeries are negatively impacting the market growth. Conversely, the high growth potential in emerging countries offers lucrative opportunities for growth of the market.

The global surgical glue market is segmented on the basis of product, application, end user, and region. By product, the market is classified into natural and synthetic & semi-synthetic. By application, it is classified into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. By end user, it is classified into hospitals, ambulatory surgery centers, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major companies profiled in the report include Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Integra Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Ocular Therapeutix Inc., and OptMed, Inc.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical glue market analysis from 2021 to 2031 to identify the prevailing surgical glue market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the surgical glue market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global surgical glue market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End user

• Hospitals
• Ambulatory Surgical Centers
• Others

By Product

• Natural
• Synthetic and Semi Synthetic

By Application

• Central Nervous System Surgeries
• General Surgeries
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Cosmetic Surgeries
• Ophthalmic Surgeries
• Urological Surgeries
• Pulmonary Surgeries
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Cohera Medical, Inc.
  • CryoLife Inc.
  • CSL Limited
  • Johnson & Johnson
  • Ocular Therapeutix Inc.
  • Sanofi
  • Sealantis Ltd.
  • Vivostat

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SURGICAL GLUE MARKET, BY PRODUCT

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Natural
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market share analysis by country
• 4.3 Synthetic and Semi Synthetic
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market share analysis by country

CHAPTER 5: SURGICAL GLUE MARKET, BY APPLICATION

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Central Nervous System Surgeries
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market share analysis by country
• 5.3 General Surgeries
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market share analysis by country
• 5.4 Cardiovascular Surgeries
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market share analysis by country
• 5.5 Orthopedic Surgeries
  • 5.5.1 Key market trends, growth factors and opportunities
  • 5.5.2 Market size and forecast, by region
  • 5.5.3 Market share analysis by country
• 5.6 Cosmetic Surgeries
  • 5.6.1 Key market trends, growth factors and opportunities
  • 5.6.2 Market size and forecast, by region
  • 5.6.3 Market share analysis by country
• 5.7 Ophthalmic Surgeries
  • 5.7.1 Key market trends, growth factors and opportunities
  • 5.7.2 Market size and forecast, by region
  • 5.7.3 Market share analysis by country
• 5.8 Urological Surgeries
  • 5.8.1 Key market trends, growth factors and opportunities
  • 5.8.2 Market size and forecast, by region
  • 5.8.3 Market share analysis by country
• 5.9 Pulmonary Surgeries
  • 5.9.1 Key market trends, growth factors and opportunities
  • 5.9.2 Market size and forecast, by region
  • 5.9.3 Market share analysis by country
• 6.0 Others
  • 6.0.1 Key market trends, growth factors and opportunities
  • 6.0.2 Market size and forecast, by region
  • 6.0.3 Market share analysis by country

CHAPTER 6: SURGICAL GLUE MARKET, BY END USER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Hospitals
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market share analysis by country
• 6.3 Ambulatory Surgical Centers
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market share analysis by country
• 6.4 Others
  • 6.4.1 Key market trends, growth factors and opportunities
  • 6.4.2 Market size and forecast, by region
  • 6.4.3 Market share analysis by country

CHAPTER 7: SURGICAL GLUE MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Product
  • 7.2.3 North America Market size and forecast, by Application
  • 7.2.4 North America Market size and forecast, by End user
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Key market trends, growth factors and opportunities
    • 7.2.5.1.2 Market size and forecast, by Product
    • 7.2.5.1.3 Market size and forecast, by Application
    • 7.2.5.1.4 Market size and forecast, by End user
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Key market trends, growth factors and opportunities
    • 7.2.5.2.2 Market size and forecast, by Product
    • 7.2.5.2.3 Market size and forecast, by Application
    • 7.2.5.2.4 Market size and forecast, by End user
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Key market trends, growth factors and opportunities
    • 7.2.5.3.2 Market size and forecast, by Product
    • 7.2.5.3.3 Market size and forecast, by Application
    • 7.2.5.3.4 Market size and forecast, by End user
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Product
  • 7.3.3 Europe Market size and forecast, by Application
  • 7.3.4 Europe Market size and forecast, by End user
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Key market trends, growth factors and opportunities
    • 7.3.5.1.2 Market size and forecast, by Product
    • 7.3.5.1.3 Market size and forecast, by Application
    • 7.3.5.1.4 Market size and forecast, by End user
    • 7.3.5.2 France
    • 7.3.5.2.1 Key market trends, growth factors and opportunities
    • 7.3.5.2.2 Market size and forecast, by Product
    • 7.3.5.2.3 Market size and forecast, by Application
    • 7.3.5.2.4 Market size and forecast, by End user
    • 7.3.5.3 UK
    • 7.3.5.3.1 Key market trends, growth factors and opportunities
    • 7.3.5.3.2 Market size and forecast, by Product
    • 7.3.5.3.3 Market size and forecast, by Application
    • 7.3.5.3.4 Market size and forecast, by End user
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Key market trends, growth factors and opportunities
    • 7.3.5.4.2 Market size and forecast, by Product
    • 7.3.5.4.3 Market size and forecast, by Application
    • 7.3.5.4.4 Market size and forecast, by End user
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Key market trends, growth factors and opportunities
    • 7.3.5.5.2 Market size and forecast, by Product
    • 7.3.5.5.3 Market size and forecast, by Application
    • 7.3.5.5.4 Market size and forecast, by End user
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Key market trends, growth factors and opportunities
    • 7.3.5.6.2 Market size and forecast, by Product
    • 7.3.5.6.3 Market size and forecast, by Application
    • 7.3.5.6.4 Market size and forecast, by End user
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Product
  • 7.4.3 Asia-Pacific Market size and forecast, by Application
  • 7.4.4 Asia-Pacific Market size and forecast, by End user
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 Japan
    • 7.4.5.1.1 Key market trends, growth factors and opportunities
    • 7.4.5.1.2 Market size and forecast, by Product
    • 7.4.5.1.3 Market size and forecast, by Application
    • 7.4.5.1.4 Market size and forecast, by End user
    • 7.4.5.2 China
    • 7.4.5.2.1 Key market trends, growth factors and opportunities
    • 7.4.5.2.2 Market size and forecast, by Product
    • 7.4.5.2.3 Market size and forecast, by Application
    • 7.4.5.2.4 Market size and forecast, by End user
    • 7.4.5.3 India
    • 7.4.5.3.1 Key market trends, growth factors and opportunities
    • 7.4.5.3.2 Market size and forecast, by Product
    • 7.4.5.3.3 Market size and forecast, by Application
    • 7.4.5.3.4 Market size and forecast, by End user
    • 7.4.5.4 Australia
    • 7.4.5.4.1 Key market trends, growth factors and opportunities
    • 7.4.5.4.2 Market size and forecast, by Product
    • 7.4.5.4.3 Market size and forecast, by Application
    • 7.4.5.4.4 Market size and forecast, by End user
    • 7.4.5.5 South Korea
    • 7.4.5.5.1 Key market trends, growth factors and opportunities
    • 7.4.5.5.2 Market size and forecast, by Product
    • 7.4.5.5.3 Market size and forecast, by Application
    • 7.4.5.5.4 Market size and forecast, by End user
    • 7.4.5.6 Rest of Asia-Pacific
    • 7.4.5.6.1 Key market trends, growth factors and opportunities
    • 7.4.5.6.2 Market size and forecast, by Product
    • 7.4.5.6.3 Market size and forecast, by Application
    • 7.4.5.6.4 Market size and forecast, by End user
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Product
  • 7.5.3 LAMEA Market size and forecast, by Application
  • 7.5.4 LAMEA Market size and forecast, by End user
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Key market trends, growth factors and opportunities
    • 7.5.5.1.2 Market size and forecast, by Product
    • 7.5.5.1.3 Market size and forecast, by Application
    • 7.5.5.1.4 Market size and forecast, by End user
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Key market trends, growth factors and opportunities
    • 7.5.5.2.2 Market size and forecast, by Product
    • 7.5.5.2.3 Market size and forecast, by Application
    • 7.5.5.2.4 Market size and forecast, by End user
    • 7.5.5.3 South Africa
    • 7.5.5.3.1 Key market trends, growth factors and opportunities
    • 7.5.5.3.2 Market size and forecast, by Product
    • 7.5.5.3.3 Market size and forecast, by Application
    • 7.5.5.3.4 Market size and forecast, by End user
    • 7.5.5.4 Rest of LAMEA
    • 7.5.5.4.1 Key market trends, growth factors and opportunities
    • 7.5.5.4.2 Market size and forecast, by Product
    • 7.5.5.4.3 Market size and forecast, by Application
    • 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 Baxter International Inc.
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 B. Braun Melsungen AG
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 Cohera Medical, Inc.
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 CryoLife Inc.
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 CSL Limited
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 Johnson & Johnson
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Ocular Therapeutix Inc.
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Sanofi
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Sealantis Ltd.
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 Vivostat
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments